Published in J Perinat Med on September 01, 2013
Removal of Soluble Fms-Like Tyrosine Kinase-1 by Dextran Sulfate Apheresis in Preeclampsia. J Am Soc Nephrol (2015) 1.25
Hepatic rupture: a rare but serious complication of HELLP syndrome. J Perinat Med (2014) 1.06
Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice. Ultrasound Obstet Gynecol (2015) 0.88
Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration. Int J Mol Sci (2015) 0.75
Association of maternal hypertensive disorders with retinopathy of prematurity: A systematic review and meta-analysis. PLoS One (2017) 0.75
Preeclampsia and Vascular Function: A Window to Future Cardiovascular Disease Risk. J Womens Health (Larchmt) (2016) 0.75
Reply to: hepatic rupture - a rare but serious complication of HELLP syndrome. J Perinat Med (2014) 0.75
Expression of placental growth factor mRNA in preeclampsia. Int J Reprod Biomed (Yazd) (2017) 0.75
WHO analysis of causes of maternal death: a systematic review. Lancet (2006) 20.24
Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00
Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest (2003) 13.72
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol (2000) 11.11
ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol (2002) 7.40
Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06
The global impact of pre-eclampsia and eclampsia. Semin Perinatol (2009) 5.50
A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate. J Matern Fetal Neonatal Med (2008) 3.39
Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation (2011) 3.33
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol (2009) 1.92
A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia. J Matern Fetal Neonatal Med (2009) 1.84
Overview of maternal morbidity during hospitalization for labor and delivery in the United States: 1993-1997 and 2001-2005. Obstet Gynecol (2009) 1.72
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol (2011) 1.50
Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol (2005) 1.48
Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol (2007) 1.47
Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol (2006) 1.16
Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation. Am J Obstet Gynecol (2004) 1.15
Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension (2007) 1.13
The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome. J Matern Fetal Neonatal Med (2010) 1.03
Effect of steroids on angiogenic factors in pregnant women with HELLP syndrome. J Perinat Med (2011) 0.82
Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia. Circulation (2011) 3.33
Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia. N Engl J Med (2016) 2.99
Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature (2012) 2.27
Preeclampsia: the role of angiogenic factors in its pathogenesis. Physiology (Bethesda) (2009) 2.10
An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol (2009) 1.92
Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension (2012) 1.86
Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study. Circ Cardiovasc Imaging (2012) 1.65
The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients. Am J Obstet Gynecol (2011) 1.50
Angiotensin II type 1 receptor agonistic antibodies reflect fundamental alterations in the uteroplacental vasculature. Hypertension (2005) 1.48
First trimester vitamin D, vitamin D binding protein, and subsequent preeclampsia. Hypertension (2010) 1.39
Effect of terminated fetal circulation on maternal angiogenic factors in severe early preeclampsia. Hypertens Pregnancy (2012) 1.39
Natriuretic peptide system in fetal heart and circulation. J Hypertens (2002) 1.38
New gestational phase-specific cutoff values for the use of the soluble fms-like tyrosine kinase-1/placental growth factor ratio as a diagnostic test for preeclampsia. Hypertension (2013) 1.20
Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol (Oxf) (2012) 1.14
Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am (2010) 1.11
The use of angiogenic biomarkers to differentiate non-HELLP related thrombocytopenia from HELLP syndrome. J Matern Fetal Neonatal Med (2010) 1.03
Role of oxidative stress and antioxidant supplementation in pregnancy disorders. Am J Clin Nutr (2011) 1.01
Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci (Lond) (2012) 1.00
Cardiomyocyte-restricted over-expression of C-type natriuretic peptide prevents cardiac hypertrophy induced by myocardial infarction in mice. Eur J Heart Fail (2007) 0.99
Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med (2006) 0.98
Fibrosis rather than blood pressure determines cardiac BNP expression in mice. Regul Pept (2003) 0.97
Risk for developing gestational diabetes in women with twin pregnancies. J Matern Fetal Neonatal Med (2009) 0.97
Serum fibroblast growth factor 21 levels in gestational diabetes mellitus in relation to insulin resistance and dyslipidemia. Metabolism (2009) 0.96
Umbilical cord hypercoiling and thinning: a rare cause of intrauterine death in the second trimester of pregnancy. Pediatr Dev Pathol (2006) 0.96
Circulating soluble endoglin and placental abruption. Prenat Diagn (2008) 0.93
The promise of angiogenic markers for the early diagnosis and prediction of preeclampsia. Clin Chem (2012) 0.92
Physicians' knowledge of future vascular disease in women with preeclampsia. Hypertens Pregnancy (2011) 0.92
Serum levels of the adipokine visfatin are increased in pre-eclampsia. Clin Endocrinol (Oxf) (2008) 0.91
The preeclampsia biomarkers soluble fms-like tyrosine kinase-1 and placental growth factor: current knowledge, clinical implications and future application. Eur J Obstet Gynecol Reprod Biol (2010) 0.91
Robust fetal ECG extraction and detection from abdominal leads. Physiol Meas (2014) 0.91
Multicenter prospective clinical study to evaluate the prediction of short-term outcome in pregnant women with suspected preeclampsia (PROGNOSIS): study protocol. BMC Pregnancy Childbirth (2014) 0.89
Midpregnancy levels of angiogenic markers in relation to maternal characteristics. Am J Obstet Gynecol (2010) 0.89
Circulating levels of the adipokine chemerin in gestational diabetes mellitus. Horm Res Paediatr (2010) 0.88
Secretory products from human adipocytes impair endothelial function via nuclear factor kappaB. Atherosclerosis (2007) 0.87
Increased Perinatal Morbidity and Mortality Among Asian American and Pacific Islander Women in the United States. Anesth Analg (2017) 0.86
Rupture of the posterior cul-de-sac during spontaneous labor. Obstet Gynecol (2010) 0.86
Secretory products from human adipocytes stimulate proinflammatory cytokine secretion from human endothelial cells. J Cell Biochem (2009) 0.86
Use of circulating antiangiogenic factors to differentiate other hypertensive disorders from preeclampsia in a pregnant woman on dialysis. Am J Kidney Dis (2008) 0.86
Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol (2008) 0.86
Short-term couplings of the cardiovascular system in pregnant women suffering from pre-eclampsia. Philos Trans A Math Phys Eng Sci (2010) 0.84
Classification of cardiovascular time series based on different coupling structures using recurrence networks analysis. Philos Trans A Math Phys Eng Sci (2013) 0.84
Agonist autoantibodies against the angiotensin AT1 receptor in renal and hypertensive disorders. Curr Hypertens Rep (2007) 0.83
Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptide. Biol Chem (2004) 0.83
Influence of the sFlt-1/PlGF ratio on clinical decision-making in women with suspected preeclampsia--the PreOS study protocol. Hypertens Pregnancy (2015) 0.83
Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors. Obstet Gynecol (2007) 0.83
Soluble fms-like tyrosine kinase 1. N Engl J Med (2004) 0.82
Effect of steroids on angiogenic factors in pregnant women with HELLP syndrome. J Perinat Med (2011) 0.82
Knock-down of endothelial connexins impairs angiogenesis. Pharmacol Res (2011) 0.82
Circulating levels of the antiangiogenic marker soluble FMS-like tyrosine kinase 1 are elevated in women with pregestational diabetes and preeclampsia: angiogenic markers in preeclampsia and preexisting diabetes. Diabetes Care (2007) 0.81
Questionable role of the angiotensin II receptor subtype 1 autoantibody in the pathogenesis of preeclampsia. Hypertension (2007) 0.81
Cells on a chip--the use of electric properties for highly sensitive monitoring of blood-derived factors involved in angiotensin II type 1 receptor signalling. Cell Physiol Biochem (2005) 0.81
Interinstitutional variations in mode of birth after a previous caesarean section: a cross-sectional study in six German hospitals. J Perinat Med (2015) 0.81
Immunohistochemical localization of alpha-tocopherol transfer protein and lipoperoxidation products in human first-trimester and term placenta. Eur J Obstet Gynecol Reprod Biol (2008) 0.80
Soluble fms-Like Tyrosine Kinase-1-to-Placental Growth Factor Ratio and Time to Delivery in Women With Suspected Preeclampsia. Obstet Gynecol (2016) 0.80
Placental expression of angiogenic factors in Trisomy 13. Am J Obstet Gynecol (2011) 0.80
Maternal risk factors for neonatal necrotizing enterocolitis. J Matern Fetal Neonatal Med (2014) 0.80
Circulating high-molecular-weight adiponectin is upregulated in preeclampsia and is related to insulin sensitivity and renal function. Eur J Endocrinol (2008) 0.80
Circulating lymphangiogenic factors in preeclampsia. Hypertens Pregnancy (2012) 0.80
The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy (2013) 0.79
Fetal cheek-to-cheek diameter in the prediction of mode of delivery. Am J Obstet Gynecol (2005) 0.79
Angiogenic factors in preeclampsia: potential for diagnosis and treatment. Curr Opin Nephrol Hypertens (2013) 0.79
Early-pregnancy soluble Fas levels in idiopathic small-for-gestational-age pregnancies. Am J Obstet Gynecol (2010) 0.79
Longitudinal analysis of heart rate variability in chronic hypertensive pregnancy. Hypertens Res (2005) 0.79
A combined technique for predicting pre-eclampsia: concurrent measurement of uterine perfusion and analysis of heart rate and blood pressure variability. J Hypertens (2006) 0.79
Fetal, neonatal cord, and maternal plasma concentrations of angiotensin-converting enzyme (ACE). Prenat Diagn (2002) 0.78
Autocrine control of angiogenesis by endogenous acetylcholine in an in vitro model using human endothelial cells: evidence for an autocrine cholinergic system in endothelial cells. J Cardiovasc Pharmacol (2015) 0.78
Serum levels of the adipokine adipocyte fatty acid-binding protein are increased in preeclampsia. Am J Hypertens (2008) 0.78
Intravital high-frequency ultrasonography to evaluate cardiovascular and uteroplacental blood flow in mouse pregnancy. Pregnancy Hypertens (2011) 0.78
Modeling risk for severe adverse outcomes using angiogenic factor measurements in women with suspected preterm preeclampsia. Prenat Diagn (2015) 0.78
A case of maternal PKU syndrome despite intensive patient counseling. Wien Med Wochenschr (2009) 0.78
Endogenous soluble receptor for advanced glycation endproducts is increased in preeclampsia. J Hypertens (2008) 0.77
Relationship between nulliparity and preeclampsia may be explained by altered circulating soluble fms-like tyrosine kinase 1. Hypertens Pregnancy (2013) 0.77
Placental lesions of vascular insufficiency are associated with anti-angiogenic state in women with preeclampsia. Hypertens Pregnancy (2014) 0.77
Management of abnormal serum markers in the absence of aneuploidy or neural tube defects. J Matern Fetal Neonatal Med (2012) 0.77
Angiogenic factors and pregnant woman with new onset seizures. Hypertens Pregnancy (2012) 0.77
Relation between maternal angiogenic factors and utero-placental resistance in normal first- and second-trimester pregnancies. Hypertens Pregnancy (2010) 0.77
Quantifying the causal strength of multivariate cardiovascular couplings with momentary information transfer. Physiol Meas (2015) 0.77
The Impact of Magnesium Sulfate Therapy on Angiogenic Factors in Preeclampsia. Pregnancy Hypertens (2012) 0.77
The impact of uterine curettage postpartum on maternal sFlt-1 concentration. J Perinat Med (2016) 0.76
Cardiovascular variability before and after delivery: recovery from arterial stiffness in women with preeclampsia 4 days post partum. Hypertens Pregnancy (2013) 0.76
A mass spectrometric multicenter study supports classification of preeclampsia as heterogeneous disorder. Hypertens Pregnancy (2012) 0.76
Preeclampsia and the risk of large-for-gestational-age infants. Am J Obstet Gynecol (2011) 0.76
Placental origins of angiogenic dysfunction in mirror syndrome. Hypertens Pregnancy (2011) 0.76
Glucose tolerance in women 24 h postpartum is related to blood pressure, anthropometric data, and adipokine serum levels. Hypertens Pregnancy (2012) 0.76
Mid-pregnancy levels of angiogenic markers as indicators of pathways to preterm delivery. J Matern Fetal Neonatal Med (2011) 0.75
Reply to: hepatic rupture - a rare but serious complication of HELLP syndrome. J Perinat Med (2014) 0.75
Urinary angiogenic factors in preeclampsia. Am J Obstet Gynecol (2005) 0.75
Autonomic cardiovascular control in pregnancies with abnormal uterine perfusion. Am J Hypertens (2006) 0.75
Angiogenic factors and renal disease in pregnancy. Case Rep Obstet Gynecol (2011) 0.75
Nicotine effects on human endothelial intercellular communication via α4β2 and α3β2 nicotinic acetylcholine receptor subtypes. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.75
Impulsive aggressiveness of pregnant women affects the development of the fetal heart. Int J Psychophysiol (2009) 0.75
EXIT procedure in a neonate with a prenatally diagnosed granular cell tumor. Pediatr Surg Int (2010) 0.75
Application of tissue microarrays in placental research. Ann Diagn Pathol (2008) 0.75
Cervical immunoglobulin A and altered vaginal flora in pregnant women with threatened preterm delivery. J Perinat Med (2004) 0.75
134: CARDIOTOXIC EFFECTS OF HYPERTENSION DURING PREGNANCY. Crit Care Med (2016) 0.75
Changes of blood pressure and heart rate variability precede a grand mal seizure in a pregnant woman. J Perinat Med (2004) 0.75
Increased cardiorespiratory coordination in preeclampsia. Physiol Meas (2017) 0.75
A rare case of congenital choroid plexus carcinoma. Pediatr Hematol Oncol (2012) 0.75
The Gini coefficient: a methodological pilot study to assess fetal brain development employing postmortem diffusion MRI. Pediatr Radiol (2014) 0.75